FABP7 is a potential biomarker to predict response to neoadjuvant chemotherapy for breast cancer

BACKGROUND: Early prediction of response to neoadjuvant chemotherapy (NAC) is critical in choosing appropriate chemotherapeutic regimen for patients with locally advanced breast cancer. Herein, we sought to identify potential biomarkers to predict the response to neoadjuvant chemotherapy for breast...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Qin, Xiao, Ying-sheng, Jia, Shi-cheng, Zheng, Jie-xuan, Du, Zhen-chao, Chen, Yi-chun, Chen, Mu-tong, Liang, Yuan-ke, Lin, Hao-yu, Zeng, De
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7684949/
https://www.ncbi.nlm.nih.gov/pubmed/33292226
http://dx.doi.org/10.1186/s12935-020-01656-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7684949/
https://www.ncbi.nlm.nih.gov/pubmed/33292226
http://dx.doi.org/10.1186/s12935-020-01656-3

Ejemplares similares